Mission Statement, Vision, & Core Values (2026) of China Reform Health Management and Services Group Co., Ltd.

From its founding in 1986 and Shenzhen Stock Exchange listing in 1992 to its strategic state-controlled transformation in 2017, China Reform Health Management and Services Group Co., Ltd. (000503.SZ) has positioned itself at the crossroads of tradition and innovation by championing the national strategy for Traditional Chinese Medicine (TCM) while scaling integrated health services-today the Beijing-headquartered group uniquely operates as the only company in China with a pharmaceutical e-commerce license and a designated government procurement e-platform, driving digital channels that accounted for about 25% of revenue in 2022 (online sales of ¥600 million within total direct sales of ≈¥1.5 billion), all underpinned by core values of integrity, dedication, perseverance and the pursuit of excellence as it builds a sustainable, synergistic TCM industry chain and seeks leadership in high-quality healthcare development

China Reform Health Management and Services Group Co., Ltd. (000503.SZ) - Intro

• Only company in China with a pharmaceutical e-commerce license and designated e-commerce platform for government procurement.
• National coverage via offline and online channels supporting public and private healthcare stakeholders.
• Strategic focus on digital transformation and integrated service models.

• Patient- and client-first: prioritize safety, accessibility and satisfaction.
• Integrity and compliance: strict adherence to regulatory and procurement standards.
• Innovation: continuous investment in digital platforms and service models.
• Collaboration: partnerships across public sector, medical institutions and suppliers.
• Quality-driven operations: evidence-based management and supplier vetting.

• Integrated service delivery - medical insurance management, pharmaceutical distribution, health services.
• Digital transformation - online platforms to expand access and efficiency.
• Public procurement leadership - designated e-commerce platform for government purchases.
• State-backed capitalization and governance - access to public-sector resources and strategic projects.

• Online sales contribution to total revenue: ~25% in 2022.
• Designated government procurement e-commerce role improves market visibility and transaction volumes.

• Exclusive pharma e-commerce license and government procurement designation - unique regulatory moat.
• Long operating history (since 1986) and public listing (since 1992) - established market presence.
• State-controlled ownership since 2017 - enhanced access to public-sector projects and capital.
• Diversified client base across public institutions and private entities - balanced revenue streams.

China Reform Health Management and Services Group Co., Ltd. (000503.SZ) - Overview

• Mission focus: Promote sustainable, high‑quality development of TCM across prevention, diagnosis, treatment, rehabilitation, and health management.
• Strategic alignment: Support national targets (e.g., Healthy China 2030's life‑expectancy and health‑service objectives) through TCM integration into primary care and public health initiatives.
• Value proposition: Combine traditional therapies with evidence‑based clinical practice, digital health platforms, and service standardization to broaden access and improve outcomes.

• Clinical service quality - drive standardized protocols, clinical pathways, and accreditation in TCM hospitals and clinics.
• Innovation & R&D - invest in evidence generation, modern formulation, and regulatory compliance for TCM products and services.
• Integration & partnerships - collaborate with public health authorities, tertiary hospitals, and community health centers to embed TCM in care continuums.
• Education & heritage preservation - train practitioners, certify skills, and protect intangible cultural assets of TCM.

• Service quality metrics: patient satisfaction, clinical outcome measures, accreditation rates for TCM facilities.
• Access metrics: number of integrated clinics/hospitals, community outreach programs, telehealth consultations.
• Innovation metrics: R&D projects, clinical trials, evidence publications, product registrations.
• Financial sustainability metrics: revenue diversification across services, per‑patient revenue, margin improvements driven by higher‑value integrated care.

China Reform Health Management and Services Group Co., Ltd. (000503.SZ) - Mission Statement

• Provide accessible, evidence-informed TCM clinical services across urban and rural markets.
• Build scalable, sustainable service platforms linking hospitals, clinics, rehabilitation centers, and community health networks.
• Foster innovation in TCM research and productization to translate traditional practice into standardized, quality-controlled therapies and preventive solutions.
• Create measurable health outcomes while delivering consistent financial returns for investors and partners.

• Sustainability: committed to long-term growth, environmental responsibility, and preserving TCM's cultural and clinical relevance.
• Mutual synergy: drive collaboration among healthcare providers, academic researchers, regulators, and community partners to amplify impact.
• Leadership: aim to set industry standards, scale best practices, and influence national and regional TCM policy and care models.
• Global alignment: position TCM as a complementary pillar of integrative healthcare amid rising demand for holistic, preventive medicine.

• Integrated care networks - expand franchise and self-owned clinic footprint while linking referral pathways into higher-tier hospitals and rehab facilities to ensure continuum of care.
• Standardization & quality control - implement clinical pathways, EMR-integrated TCM protocols, and product GMP standards to raise reproducibility and outcomes.
• Digital transformation - deploy telemedicine, remote monitoring, and AI-driven decision support to broaden rural access and optimize resource use.
• R&D and productization - invest in clinical trials, active-ingredient standardization, and commercial preparation of TCM formulations.
• Partnerships & talent cultivation - collaborate with universities, research institutes, and government programs to train practitioners and co-develop innovations.

• Patient-centeredness - prioritize measurable patient outcomes, safety, and individualized care plans.
• Integrity & compliance - adhere to regulatory standards, transparent reporting, and ethical practice in all markets.
• Collaboration - pursue win-win relationships across the health ecosystem to generate shared value.
• Innovation - balance respect for traditional knowledge with rigorous scientific validation and modern delivery models.
• Sustainability - integrate environmental stewardship and financially sustainable models for long-term service continuity.

China Reform Health Management and Services Group Co., Ltd. (000503.SZ) - Vision Statement

• Build a nationwide, vertically integrated TCM service network that delivers standardized clinical care, prevention, rehabilitation, and health management.
• Leverage digitalization and big data to enable personalized TCM interventions, remote diagnosis, and population health management at scale.
• Establish China Reform as a benchmark for quality, safety, and innovation in TCM, improving public trust and international recognition of Chinese medicine.
• Drive industry consolidation and capability uplift through strategic partnerships, M&A, and talent development.

• Integrity - Honesty, transparency, and strict compliance guide clinical practice, supplier relationships, financial reporting, and stakeholder communications.
• Dedication - Commitment to advancing TCM and comprehensive healthcare underpins research, patient care, and community health programs.
• Perseverance - A long-term orientation enables the company to navigate regulatory change, scale clinical standards, and sustain capital investments in R&D and infrastructure.
• Pursuit of Excellence - Continuous improvement in clinical outcomes, service quality, and operational efficiency drives target-setting and performance management.

• Standardization & Quality - Implement company-wide clinical protocols, electronic medical records (EMR) specialization for TCM, and a centralized quality-management office to reduce variability and improve safety metrics.
• Digital Health & Data - Scale telemedicine, chronic disease management platforms, and AI-assisted TCM diagnostic support to increase patient reach and operational efficiency; leverage aggregated clinical data to support outcomes research.
• R&D & Evidence Generation - Expand clinical studies and real-world evidence programs for key TCM modalities; allocate rising R&D spend to bolster product pipelines and international registration efforts.
• Talent & Training - Invest in continuous professional development, standardized certification for practitioners, and cross-disciplinary teams integrating modern medicine and TCM.
• Partnerships & M&A - Pursue selective acquisitions of regional chains and strategic alliances with research institutes to accelerate network growth and capability acquisition.

• Transparent reporting - Strengthen disclosure of clinical outcomes, safety events, and ESG metrics to investors and regulators.
• Community health - Expand preventive care and chronic disease programs targeting aging populations and rural areas.
• Supplier ethics - Enforce procurement standards and anti-corruption controls across the supply chain.
• Investor engagement - Regular updates on strategic execution, capital allocation, and M&A outcomes to enhance market confidence.